Cargando…
Molecular markers of prognosis in canine cortisol‐secreting adrenocortical tumours
Hypercortisolism is caused by a cortisol‐secreting adrenocortical tumour (ACT) in approximately 15%‐20% of cases in dogs. Little is known about which molecular markers are associated with malignant behaviour of canine ACTs. The objective of this study was to identify molecular markers of prognosis,...
Autores principales: | Sanders, Karin, van Staalduinen, Gerjanne J., Uijens, Maarten C. M., Mol, Jan A., Teske, Erik, Slob, Adri, Hesselink, Jan Willem, Kooistra, Hans S., Galac, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899893/ https://www.ncbi.nlm.nih.gov/pubmed/31301217 http://dx.doi.org/10.1111/vco.12521 |
Ejemplares similares
-
The Utrecht Score: A novel histopathological scoring system to assess the prognosis of dogs with cortisol‐secreting adrenocortical tumours
por: Sanders, Karin, et al.
Publicado: (2019) -
Insulin‐Like Growth Factor—Phosphatidylinositol 3 Kinase Signaling in Canine Cortisol‐Secreting Adrenocortical Tumors
por: Kool, M.M.J., et al.
Publicado: (2015) -
Melanocortin 2 Receptor Antagonists in Canine Cushing’s Disease: In Vitro Studies
por: Sanders, Karin, et al.
Publicado: (2021) -
TRH-induced secretion of adrenocorticotropin and cortisol in dogs with pituitary-dependent hypercortisolism
por: Pijnacker, Tera, et al.
Publicado: (2018) -
New Insights in the Functional Zonation of the Canine Adrenal Cortex
por: Sanders, K., et al.
Publicado: (2016)